DexCom financials
$86.64−0.05%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.31B | $1.19B | $1.26B | $1.21B | $1.16B | $1.04B | $1.11B | $994.2M | $1.00B | $921.0M | $1.03B | $975.0M |
| Gross profit | $830.0M | $750.3M | $792.7M | $731.4M | $688.8M | $589.0M | $655.8M | $593.8M | $626.7M | $561.9M | $656.6M | $623.3M |
| Gross margin | 63.4% | 62.9% | 62.9% | 60.5% | 59.5% | 56.9% | 58.9% | 59.7% | 62.4% | 61.0% | 63.5% | 63.9% |
| Operating income | $318.3M | $255.3M | $323.0M | $242.5M | $212.6M | $133.7M | $188.9M | $152.0M | $158.0M | $101.1M | $216.9M | $205.5M |
| Net income | $249.1M | $199.5M | $267.3M | $283.8M | $179.8M | $105.4M | $151.7M | $134.6M | $143.5M | $146.4M | $256.3M | $120.7M |
| Net margin | 19.0% | 16.7% | 21.2% | 23.5% | 15.5% | 10.2% | 13.6% | 13.5% | 14.3% | 15.9% | 24.8% | 12.4% |
| Diluted EPS | $0.64 | $0.51 | $0.67 | $0.70 | $0.45 | $0.27 | $0.37 | $0.34 | $0.35 | $0.36 | $0.60 | $0.29 |
| EBITDA | $386.5M | $322.4M | $388.2M | $306.1M | $275.6M | $193.7M | $246.7M | $207.3M | $210.1M | $153.6M | $216.9M | $253.7M |
| Operating cash flow | $269.2M | $525.6M | $294.0M | $659.9M | $303.0M | $183.8M | $301.4M | $199.5M | $279.4M | $209.2M | $133.6M | $269.2M |
| Free cash flow | $184.5M | $449.0M | $192.1M | $579.4M | $208.9M | $96.8M | $176.8M | $88.3M | $213.3M | $152.3M | $81.1M | $218.8M |
| Diluted shares | 390.1M | 393.6M | 398.9M | 407.4M | 408.2M | 407.5M | 407.1M | 410.2M | 416.8M | 416.7M | 425.2M | 426.8M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.10B | $1.12B | $917.7M | $1.84B | $1.16B | $904.9M |
| Short-term investments | $842.0M | $1.30B | $1.08B | $1.49B | $1.77B | $1.80B |
| Total debt | $1.24B | $1.24B | $1.24B | $2.45B | $2.44B | $2.44B |
| Total assets | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B |
| Total liabilities | $3.83B | $3.68B | $3.59B | $4.77B | $4.75B | $4.49B |
| Shareholders' equity | $2.62B | $2.96B | $2.75B | $2.73B | $2.57B | $2.27B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology